Noninvasive fetal RHD genotyping to guide targeted anti-D prophylaxis-an external quality assessment workshop.

Frederik Banch ClausenAngela Natalie Barrettnull null

Published in: Vox sanguinis (2019)

This external quality assessment workshop demonstrates that despite the different approaches taken to perform the clinical assays, fetal RHD genotyping is a reliable laboratory assay to guide targeted use of Rh prophylaxis in a clinical setting.

Keyphrases

high throughput
genome wide
cancer therapy
gene expression
dna methylation
genetic diversity